期刊文献+

炎症在维持性血液透析患者血管内皮损伤中作用及抗炎治疗 被引量:6

下载PDF
导出
摘要 终末期肾病(end-stage renal disease,ESRD)血液透析患者心血管疾病发病率较高,因其存在炎症和氧化应激可致内皮功能紊乱,促进心血管疾病的发生。理论上,成功的血液透析过程可以清除蓄积的毒素,逆转炎症和氧化应激,进而减少动脉粥样硬化的发生。然而,透析本身似乎可以加剧炎症,氧化应激和动脉粥样硬化。多种内源性和外源性因子相互作用,诱导内皮损伤和动脉粥样硬化。内源性因子包括肾衰竭患者的炎症和氧化应激成分,而外源性因子来源于透析过程本身。透析器的生物不相容性已成为增加炎症标志物的重要因素。因此,透析过程中的透析膜生物不相容性和透析不充分性可以导致更严重的后果,而不是清除了那些内源性因子。随着透析器的发展,生物相容性膜不仅可以减轻透析相关性炎症,而且可以清除更多的尿毒症毒素和中大分子,这不失为减轻内皮功能紊乱、炎症和氧化应激,并降低ESRD患者发生动脉粥样硬化风险的可行措施。
作者 李聪 陈楠
出处 《中国血液净化》 2011年第2期100-104,共5页 Chinese Journal of Blood Purification
  • 相关文献

参考文献37

  • 1Pawlak K.Naumnik B.Brzosko S,et al.Oxidative stress-a link between endothelial injury,coagulation actiration,and atherosclerosis in haemodialysis patients[J].Am J Nephrol,2004,24:154-161.
  • 2Landmesser U,Hornig B,Drexler H.Endothelial function:a critical determinant in atherosclerosis?[J].Circulation,2004,109:Ⅱ 27-33.
  • 3Pannier B,Guerin AP,Marchais SJ,et al.Postischemic rasedilation,endothelial activation,and cardiovascular remodeling in end-stage renaldisease[J].Kidney Int,2000,57:1091-1099.
  • 4Stenvinkel P.Endothelial dysfunction and inflammation-is there a link?[J].Nephrol Dial Transplant,2001,16:1968-1971.
  • 5Ronco C,Tetta C.Dialysis patients and cardiovascular problems:can technology solve the complex equation?[J].Expert Rev Med Devices,2005,2:681-687.
  • 6Zoccali C.Traditional and emerging cardiovascular and renal risk factors:an epidemiologic perspective[J].Kidney Int,2006,70:26-33.
  • 7Pecoits-Filho R,Lindholm B,Stenvinkpl P.The malnutrition,inflammation,and atherosclerosis(MIA)syndrome-the heart of the matter[J].Nephrol Dial Transplant,2002,17 Suppl 11:28-31.
  • 8Axelsson J,Heimburger O,Stenvinkel P.Adipose tissue and inflation in chronic kidney disease[J].Contrib Nephrol,2006,151:165-174.
  • 9Horl WH.Hemodialysis membranes:interleukins,biocompatibility,and middle molecules[J].J Am Soc Nephrol,2002,13 Suppl 1:S62-71.
  • 10Bricik DE,Schulak JA,Sell DR,et al.Effects of kidney or kidney-pancreas transplantation on plasma pentosidine[J].Kidney Int,1993,43:398-403.

同被引文献40

  • 1李秀丽.血液灌流串联血液透析治疗尿毒症皮肤瘙痒16例[J].解放军医药杂志,2010,22(S1):17-18. 被引量:5
  • 2丁德良,李环波.尿毒症患者C反应蛋白与贫血、营养不良及冠心病的关系[J].实用医学杂志,2006,22(17):2026-2027. 被引量:7
  • 3Chen S J,Jiang G R,Shan J P,et al.Combination of main-tenance hemodialysis with hemoperfusion:a safe and effectivemodel of artificial kidney[J].Int J Artif Organs,2011,34(4):339.
  • 4TojimbaraT,Sato S,Nakajima I,et al.Polymyxin B-immo-bilized fiber hemoperfusion after emergency surgery in pa-tients with chronic renal failure[J].Ther Apher Dial,2004,8(4):286.
  • 5Winchester J F,Ronco C,Brady J A,et al.Rationale forcombined hemoperfusion/hemodialysis in uremia[J].ContribNephrol,2001,(133):174.
  • 6Sarnatskaya V V,Yushko L A,Sakhno L A,et al.New ap-proaches to the removal of protein-bound toxins from bloodplasma of uremic patients[J].Artif Cells Blood Substit Immo-bil Biotechnol,2007,35(3):287.
  • 7Chen L H,Zhuang L,Zhang L Q,et al.Clinical analysis ofhemodialysis combined with hemoperfusion for treatment inuremic patients[J].Zhongguo Wei Zhong Bing Ji Jiu Yi Xue,2010,22(12):760.
  • 8Shafik A,Saleh M,Mahmoud A,et al.Homohemodialysis:a technique of dialysis for the uremic animal[J].Biomed SciInstrum,1997,33:509.
  • 9Taniguchi T,Takemoto Y,Tsuda K,et al.Effects of post-treatment with direct hemoperfusion using a CTR column onmortality and inflammatory responses to endotoxin-inducedshock in rats[J].Blood Purif,2006,24(5/6):460.
  • 10Vaziri ND. CKD impairs barrier function and alters microbial flora of the intestine: a major link to inflammation and uremic toxicity [J]. Current Opinion in Nephrology and Hypertension, 2012, 21(6): 587-592.

引证文献6

二级引证文献111

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部